Macrogenics (MGNX) Change in Accured Expenses (2012 - 2026)

Macrogenics (MGNX) has 15 years of Change in Accured Expenses data on file, last reported at -$3.7 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 397.04% year-over-year to -$3.7 million in Q1 2026; TTM through Mar 2026 was -$11.8 million, a 668.64% decrease from a year earlier, with the FY2025 full-year figure at -$6.8 million, down 236.6% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$3.7 million, up from -$7.8 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for MGNX reached as high as $8.6 million in Q3 2025 and fell as low as -$11.9 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$599294.1 across 5 years, with a median of -$427000.0 in 2023.
• Across the five-year window, Change in Accured Expenses slumped 1494.15% in 2022 and jumped 4229.29% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $6.3 million in 2022, then sank by 74.32% to $1.6 million in 2023, then soared by 171.0% to $4.4 million in 2024, then slumped by 278.07% to -$7.8 million in 2025, then jumped by 52.04% to -$3.7 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$3.7 million in Q1 2026, -$7.8 million in Q4 2025, and $8.6 million in Q3 2025.